Actively Recruiting
Study of Ashwagandha and Liposomal Doxorubicin Combination for Recurrent Ovarian Cancer Treatment Phase 1 and Phase 2 Clinical Trial
Led by Sham Sunder Kakar · Updated on 2026-03-19
72
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying the combination of liposomal doxorubicin DOXIL and Ashwagandha Withaferin A, ASWD in patients with recurrent ovarian cancer to determine the safe and tolerable dose of Ashwagandha alongside DOXIL. This trial includes two phases Phase I focuses on dose escalation and safety with 18 patients, and Phase II evaluates treatment response in 54 patients using the dose identified in Phase I. The study aims to understand the effectiveness and safety of this combined therapy in managing recurrent ovarian cancer. In Phase I, participants receive DOXIL intravenously every 4 weeks for up to 10 cycles or until disease progression or unacceptable toxicity occurs. Ashwagandha is given orally twice daily at escalating doses 2.0 g, 4.0 g, or 8.0 g per day to find the maximum tolerated dose. In Phase II, patients will be treated with DOXIL plus the Ashwagandha dose identified in Phase I, continuing for up to 10 cycles or until progression or toxicity. After DOXIL treatment ends, Ashwagandha may be continued daily as maintenance therapy. Participants undergo regular assessments including blood tests complete blood count, liver function, coagulation, imaging studies, and biomarker analysis to monitor treatment effects and side effects. Researchers measure progression-free survival, response rates, and overall survival up to four years. Safety is closely monitored using standardized criteria for adverse events. Participants are followed throughout treatment and for long-term outcomes, with the study lasting up to two years of treatment and additional follow-up.
CONDITIONS
Brief Title
Combination Therapy for Recurrent Ovarian Cancer
Research Team
S
Sham Kakar, PhD
W
Whitney Goldsberry, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here